Literature DB >> 19704353

Clinical inertia in depression treatment.

Rachel M Henke1, Alan M Zaslavsky, Thomas G McGuire, John Z Ayanian, Lisa V Rubenstein.   

Abstract

OBJECTIVE: To explore reasons for clinical inertia in the management of persistent depression symptoms. RESEARCH
DESIGN: We characterized patterns of treatment adjustment in primary care and their relation to the patient's clinical condition by modeling transition to a given treatment "state" conditional on the current state of treatment. We assessed associations of patient, clinician, and practice barriers with adjustment decisions.
SUBJECTS: Survey data on patients in active care for major depression were collected at 6-month intervals over a 2-year period for the quality improvement for depression (QID) studies. MEASURES: Patient and clinician characteristics were collected at baseline. Depression severity and treatment were measured at each interval.
RESULTS: Approximately, one-third of the observation periods ending with less than a full response resulted in an adjustment recommendation. Clinicians often respond correctly to the combination of severe depression symptoms and less than maximal treatment by changing the treatment. Appropriate adjustment is less common, however, in management of less severely depressed patients who do not improve after starting treatment, particularly if their care already meets minimal treatment intensity guidelines.
CONCLUSIONS: Our findings suggest that quality improvement efforts should focus on promoting appropriate adjustments for patients with persistent depression symptoms, particularly those with less severe depression.

Entities:  

Mesh:

Year:  2009        PMID: 19704353      PMCID: PMC4003881          DOI: 10.1097/MLR.0b013e31819a5da0

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  41 in total

1.  A note on robust variance estimation for cluster-correlated data.

Authors:  R L Williams
Journal:  Biometrics       Date:  2000-06       Impact factor: 2.571

2.  Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial.

Authors:  W Katon; M Von Korff; E Lin; G Simon; E Walker; J Unützer; T Bush; J Russo; E Ludman
Journal:  Arch Gen Psychiatry       Date:  1999-12

3.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Authors:  Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

4.  Factors associated with primary care clinicians' choice of a watchful waiting approach to managing depression.

Authors:  Lisa S Meredith; Wendy J Y Cheng; Scot C Hickey; Megan Dwight-Johnson
Journal:  Psychiatr Serv       Date:  2007-01       Impact factor: 3.084

Review 5.  Socio-economic status of the patient and doctor-patient communication: does it make a difference?

Authors:  S Willems; S De Maesschalck; M Deveugele; A Derese; J De Maeseneer
Journal:  Patient Educ Couns       Date:  2005-02

6.  Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.

Authors:  Alan F Schatzberg; A John Rush; Bruce A Arnow; Phillip L C Banks; Janice A Blalock; Frances E Borian; Robert Howland; Daniel N Klein; James H Kocsis; Susan G Kornstein; Rachel Manber; John C Markowitz; Ivan Miller; Philip T Ninan; Barbara O Rothbaum; Michael E Thase; Madhukar H Trivedi; Martin B Keller
Journal:  Arch Gen Psychiatry       Date:  2005-05

7.  Testing for statistical discrimination in health care.

Authors:  Ana I Balsa; Thomas G McGuire; Lisa S Meredith
Journal:  Health Serv Res       Date:  2005-02       Impact factor: 3.402

8.  Patient race/ethnicity and quality of patient-physician communication during medical visits.

Authors:  Rachel L Johnson; Debra Roter; Neil R Powe; Lisa A Cooper
Journal:  Am J Public Health       Date:  2004-12       Impact factor: 9.308

9.  Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Jonathan W Stewart; Andrew A Nierenberg; Michael E Thase; Louise Ritz; Melanie M Biggs; Diane Warden; James F Luther; Kathy Shores-Wilson; George Niederehe; Maurizio Fava
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

10.  Medication augmentation after the failure of SSRIs for depression.

Authors:  Madhukar H Trivedi; Maurizio Fava; Stephen R Wisniewski; Michael E Thase; Frederick Quitkin; Diane Warden; Louise Ritz; Andrew A Nierenberg; Barry D Lebowitz; Melanie M Biggs; James F Luther; Kathy Shores-Wilson; A John Rush
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

View more
  16 in total

1.  Testing for clinical inertia in medication treatment of bipolar disorder.

Authors:  Dominic Hodgkin; Elizabeth L Merrick; Peggy L O'Brien; Thomas G McGuire; Sue Lee; Thilo Deckersbach; Andrew A Nierenberg
Journal:  J Affect Disord       Date:  2016-06-21       Impact factor: 4.839

2.  Multilevel interventions: study design and analysis issues.

Authors:  Paul D Cleary; Cary P Gross; Alan M Zaslavsky; Stephen H Taplin
Journal:  J Natl Cancer Inst Monogr       Date:  2012-05

Review 3.  Strategies to improve the management of depression in primary care.

Authors:  Jürgen Unützer; Mijung Park
Journal:  Prim Care       Date:  2012-06       Impact factor: 2.907

Review 4.  Usual and unusual care: existing practice control groups in randomized controlled trials of behavioral interventions.

Authors:  Kenneth E Freedland; David C Mohr; Karina W Davidson; Joseph E Schwartz
Journal:  Psychosom Med       Date:  2011-05-02       Impact factor: 4.312

5.  Customization in prescribing for bipolar disorder.

Authors:  Dominic Hodgkin; Joanna Volpe-Vartanian; Elizabeth L Merrick; Constance M Horgan; Andrew A Nierenberg; Richard G Frank; Sue Lee
Journal:  Health Econ       Date:  2011-04-19       Impact factor: 3.046

6.  Web-based Mindfulness-based Cognitive Therapy for reducing residual depressive symptoms: An open trial and quasi-experimental comparison to propensity score matched controls.

Authors:  Sona Dimidjian; Arne Beck; Jennifer N Felder; Jennifer M Boggs; Robert Gallop; Zindel V Segal
Journal:  Behav Res Ther       Date:  2014-09-18

7.  Obesogenic Medications and Weight Gain Over 24 Weeks in Patients with Depression: Results from the GUIDED Study.

Authors:  Jess G Fiedorowicz; Lisa Brown; James Li; Sagar V Parikh; Boadie W Dunlop; Brent P Forester; Richard C Shelton; Michael E Thase; Matthew Macaluso; Kunbo Yu; John F Greden
Journal:  Psychopharmacol Bull       Date:  2021-11-03

8.  Psychiatric Case Review and Treatment Intensification in Collaborative Care Management for Depression in Primary Care.

Authors:  Nathaniel A Sowa; Philip Jeng; Amy M Bauer; Joseph M Cerimele; Jürgen Unützer; Yuhua Bao; Lydia Chwastiak
Journal:  Psychiatr Serv       Date:  2018-02-01       Impact factor: 3.084

9.  Older adults with severe, treatment-resistant depression.

Authors:  Jürgen Unützer; Mijung Park
Journal:  JAMA       Date:  2012-09-05       Impact factor: 56.272

10.  Grand challenges: integrating mental health services into priority health care platforms.

Authors:  Vikram Patel; Gary S Belkin; Arun Chockalingam; Janice Cooper; Shekhar Saxena; Jürgen Unützer
Journal:  PLoS Med       Date:  2013-05-28       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.